|Day Low/High||94.48 / 95.51|
|52 Wk Low/High||55.80 / 96.45|
Here's what you need to know for Wednesday, Sept. 18.
The Pharmacy Benefit Management Institute (PBMI) 2018 survey ranks Express Scripts at the top of pharmacy benefit managers (PBMs) in overall satisfaction
The most recent short interest data has been released for the 08/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Stocks are mixed on Thursday as investors brace for another potentially damaging escalation in the ongoing trade war between the U.S. and China.
U.S. stock futures rise slightly as investors brace for a potentially damaging escalation in U.S. and China trade war; the Justice Department is reportedly close to giving the green light to two mega deals in the healthcare sector; CBS and National Amusements are in settlement talks, a report says.
Here's what you need to know now for Wednesday, Sept. 5.
Inside Rx has provided patients with $160 million in savings on brand and generic medications since its inception in May 2017
Special Meeting of Stockholders to Vote on the Transaction to be held on Friday, August 24, 2018
Stocks end Tuesday with solid gains as concerns over Turkey's currency crisis ease.
U.S. stock futures rise on Tuesday as investors cautiously return to risk markets; Home Depot reports earnings; Tesla's Elon Musk says he's working with Silver Lake Partners and Goldman Sachs as advisers on his plans to take the electric car company private.
Express Scripts Reminds Stockholders to Vote "FOR" the Merger
NEW YORK, Aug. 9, 2018 /PRNewswire/ -- Fellow Cigna Shareholders: Our firm, Glenview Capital Management ("Glenview"), is a 10-year investor in Cigna (NYSE:CI), and we support the Express Scripts (NASDAQ:ESRX) transaction for the following reasons: 1.
Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.
Sometimes you gotta have faith, but you also have to be a little more skeptical.
Stocks ended higher Tuesday after China moved to support shares in Shanghai and on positive earnings and takeover talk.
Cigna argues Carl Icahn is only looking out for himself in trying to block Express Scripts deal.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's stocks from the floor of the New York Stock Exchange.
Activist investor Carl Icahn slammed Cigna's move to acquire Express Scripts.
The summer battle on Wall Street is on: Cigna vs. billionaire activist investor Carl Icahn. Stocks, meanwhile, continue to ascend to new heights despite a host of concerns.
U.S. stock futures are higher on Tuesday as earnings continue to impress; Walt Disney, Snap and Papa John's report earnings on Tuesday; the Justice Department challenges a judge's approval of the AT&T-Time Warner merger.
- 2019 National Preferred Formulary includes low list price medications in high-cost categories
Billionaire Investor Carl Icahn urged Cigna shareholders Tuesday to reject the company's planned acquisition of Express Scripts Holdings Co., calling the deal a "$60 billion folly".
After starting with a sharp selloff on the latest trade tensions with China, U.S. stocks bounced back to end mostly higher Thursday.
The Nasdaq was the lone major U.S. index to close trading in the green Wednesday.
- Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.